Forgot Password?
Return to Course Listing

CME: Ulcerative Colitis (UC): Therapeutic Updates and Emerging Therapies

ACCREDITATION EXPIRED: December 29, 2017

Activity Description / Statement of Need:

In this online CME self-learning program:

 

IBD is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are ulcerative colitis (UC) and Crohn’s disease, the former of which exclusively affects the colon and rectum. Guidelines exist for the treatment of UC, but they are constantly changing to include updated information. Despite the plethora of guidelines available, there are issues surrounding guideline adherence by physicians, patient satisfaction, the quality of treatment and a patient’s QOL. Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them, that this lack of knowledge is affecting patient satisfaction, and that there may be demographically-based barriers to care, educational programs are warranted to keep HCPs abreast of best practices in patients with UC. This program has been designed to review treatment strategies, emerging therapies, and gaps in care of patients with UC.

 

Agenda:

 

Introduction, Disclosures

Epidemiology and clinical features of UC

  • Statistics by severity
  • Causes and risk factors
  • Clinical features: endoscopic, radiologic, and histopathologic
  • UC treatment guidelines and their strengths: World Gastroenterology Organization, American College Of Gastroenterology, National Institute for Health and Care Excellence  [Learning Objective #1]

Treatment of UC

  • Medications: induction and maintenance therapy for UC [Learning Objective #2]
  • Novel and emerging therapies and approaches to the treatment of UC [Learning Objective #3]
  • Patient cases [Learning Objectives #2 & 4]

Best practice recap

Target Audience:

Healthcare professionals specializing in: gastroenterology, internal medicine, and those who otherwise commonly care for patients with UC.

This program is supported by an educational grant from SHIRE

Release Date: December 29, 2015 -- Expiration Date: December 29, 2017

Faculty: Mark Mattar, MD

Agenda

Learning Objectives

By the end of the session the participant will be able to:

  • Describe the strengths of different professional organizations� UC treatment guidelines
  • Identify the present treatment options currently available for management of UC* and apply them to patient cases using evidence-based medicine.
  • Identify new and emerging therapies for the treatment of UC.
  • Evaluate a treatment plan for a specific patient based on severity of UC to optimize safety, efficacy, and cost-efficacy, suggesting modifications for improvement.

Accreditation

THIS COURSE IS EXPIRED. NO CREDIT WILL BE ISSUED.


Faculty Disclosure and Resolution of COI

 As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

 

Faculty Disclosure:  Mark Mattar, MD discloses financial support from Abbvie.

 

Disclosures of Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.

 

Commercial Support Disclosure: This program is supported by an educational grant from SHIRE

Instructions

  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 50% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

PC
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
MAC
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.